Prone or lithotomy positioning during an abdominoperineal resection for rectal cancer results in comparable oncologic outcomes

Diseases of the Colon and Rectum

Volumn 54, Issue 8, 2011, Pages 939-946

  De Campos Lobato, Luiz Felipe ^a   Stocchi, Luca ^a   Dietz, David W ^a   Lavery, Ian C ^a   Fazio, Victor W ^a   Kalady, Matthew F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Abdominoperineal resection; Prognosis; Rectal cancer; Resection margins; Surgery

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY POSTURE; CANCER SURGERY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; LITHOTOMY POSITION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OPERATION DURATION; PELVIS ABSCESS; PERIOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM PERFORATION; REOPERATION; STOMA; SURGICAL INFECTION; TREATMENT OUTCOME; TUMOR PERFORATION; URETHRA INJURY; URINE INCONTINENCE; URINE RETENTION; VAGINAL INJURY;

AGED; ANAL CANAL; CHEMOTHERAPY, ADJUVANT; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PATIENT POSITIONING; PROGNOSIS; PRONE POSITION; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052725729     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e318221eb64     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249.
2. Wu JS, Fazio VW. Management of rectal cancer. J Gastrointest Surg. 2004;8:139-149. (Pubitemid 38224255)
3. Lavery IC, Lopez-Kostner F, Fazio VW, Fernandez-Martin M, Milsom JW, Church JM. Chances of cure are not compromised with sphincter-saving procedures for cancer of the lower third of the rectum. Surgery. 1997;122:779-785. (Pubitemid 27452590)
4. Lopez-Kostner F, Lavery IC, Hool GR, Rybicki LA, Fazio VW. Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery. 1998;124:612-618. (Pubitemid 28463255)
5. Lavery IC, Lopez-Kostner F, Pelley RJ, Fine RM. Treatment of colon and rectal cancer. Surg Clin North Am. 2000;80:535-569, ix. (Pubitemid 30227069)
6. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479-1482. (Pubitemid 16095660)
7. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer: implementation of total mesorectal excision as routine treatment in Norway: a national audit. Dis Colon Rectum. 2002;45:857-866. (Pubitemid 34761463)
8. Carlsen E, Schlichting E, Guldvog I, Johnson E, Heald RJ. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg. 1998;85:526-529. (Pubitemid 28175451)
9. Wiig JN, Carlsen E, Soreide O. Mesorectal excision for rectal cancer: a view from Europe. Semin Surg Oncol. 1998;15:78-86. (Pubitemid 28387984)
10. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991;324:709-715.
11. Goligher JC, Dukes CE, Bussey HJ. Local recurrences after sphincter saving excisions for carcinoma of the rectum and rectosigmoid. Br J Surg. 1951;39:199-211.
12. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
13. Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74-82. (Pubitemid 40917970)
14. Wibe A, Syse A, Andersen E, et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum. 2004;47:48-58. (Pubitemid 38040245)
15. Shihab OC, Brown G, Daniels IR, Heald RJ, Quirke P, Moran BJ. Patients with low rectal cancer treated by abdominoperineal excision have worse tumors and higher involved margin rates compared with patients treated by anterior resection. Dis Colon Rectum. 2010;53:53-56.
16. Tilney HS, Tekkis PP, Sains PS, Constantinides VA, Heriot AG, Association of Coloproctology of Great Britain and Ireland. Factors affecting circumferential resection margin involvement after rectal cancer excision. Dis Colon Rectum. 2007;50:29-36.
17. den Dulk M, Marijnen CA, Putter H, et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg. 2007;246:83-90. (Pubitemid 47012211)
18. den Dulk M, Putter H, Collette L, et al. The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer. 2009; 45:1175-1183.
19. Smedh K, Khani MH, Kraaz W, Raab Y, Strand E. Abdominoperineal excision with partial anterior en bloc resection in multimodal management of low rectal cancer: a strategy to reduce local recurrence. Dis Colon Rectum. 2006;49:833-840. (Pubitemid 43846619)
20. Das P, Skibber JM, Rodriguez-Bigas MA, et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006;29:219-224. (Pubitemid 44270928)
21. Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol. 1993;11: 1879-1887. (Pubitemid 23304611)
22. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 1995;345:939-944.
23. Holm T, Ljung A, Haggmark T, Jurell G, Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg. 2007;94: 232-238. (Pubitemid 46340406)
24. West NP, Finan PJ, Anderin C, Lindholm J, Holm T, Quirke P. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol. 2008;26: 3517-3522.
25. West NP, Anderin C, Smith KJ, Holm T, Quirke P, on behalf of the European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdomin-operineal excision for low rectal cancer. Br J Surg. 2010;97:588-599.
26. Miles WE. Amethod of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet. 1908;2:1812-1813.
27. de Campos-Lobato LF, Stocchi L, da Luz Moreira A, et al. Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII rectal cancers. Ann Surg Oncol. 2010;17:1758-1766.
28. Kalady MF, de Campos-Lobato LF, Stocchi L, et al. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg. 2009;250:582-589.
29. de Campos-Lobato LF, Geisler D, da Luz Moreira A, Stocchi L, Dietz D, Kalady MF. Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery. J Gastrointest Surg. 2011;15:444-450.
30. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
31. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010;28:264-271.
32. Anthony T, Simmang C, Hyman N, et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum. 2004;47:807-817. (Pubitemid 38702598)
33. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-toevent outcomes in clinical trials: good practice and pitfalls. Lancet. 2002;359:1686-1689. (Pubitemid 34518535)